Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Osteoporos Int ; 21(1): 109-18, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19373426

RESUMEN

UNLABELLED: In comparison with hip fractures, increased expression of genes in the Wnt pathway and increased Wnt activity were found in bone samples and osteoblast cultures from patients with osteoarthritis, suggesting the involvement of this pathway in subchondral bone changes. No consistent differences were found in the genetic association study. INTRODUCTION: This study aims to explore the allelic variations and expression of Wnt pathway genes in patients with osteoporosis and osteoarthritis. METHODS: The expression of 86 genes was studied in bone samples and osteoblast primary cultures from patients with hip fractures and hip or knee osteoarthritis. The Wnt-related activity was assessed by measuring AXIN2 and in transfection experiments. Fifty-five SNPs of the LRP5, LRP6, FRZB, and SOST genes were analyzed in 1,128 patients. RESULTS: Several genes were differentially expressed in bone tissue, with the lowest values usually found in hip fracture and the highest in knee osteoarthritis. Overall, seven genes were consistently upregulated both in tissue samples and in cell cultures from patients with knee osteoarthritis (BCL9, FZD5, DVL2, EP300, FRZB, LRP5, and TCF7L1). The increased expression of AXIN2 and experiments of transient transfection of osteoblasts with the TOP-Flash construct confirmed the activation of Wnt signaling. Three SNPs of the LRP5 gene and one in the LRP6 gene showed marginally significant differences in allelic frequencies across the patient groups, but they did not resist multiple-test adjustment. CONCLUSIONS: Genes in the Wnt pathway are upregulated in the osteoarthritic bone, suggesting their involvement not only in cartilage distortion but also in subchondral bone changes.


Asunto(s)
Osteoartritis/genética , Osteoporosis/genética , Proteínas Wnt/genética , Anciano , Anciano de 80 o más Años , Células Cultivadas , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética/métodos , Predisposición Genética a la Enfermedad , Genotipo , Fracturas de Cadera/genética , Fracturas de Cadera/metabolismo , Humanos , Masculino , Osteoartritis/metabolismo , Osteoartritis de la Cadera/genética , Osteoartritis de la Cadera/metabolismo , Osteoartritis de la Rodilla/genética , Osteoartritis de la Rodilla/metabolismo , Osteoblastos/metabolismo , Osteoporosis/metabolismo , Polimorfismo de Nucleótido Simple , Transducción de Señal/genética , Regulación hacia Arriba , Proteínas Wnt/metabolismo
2.
J Clin Epidemiol ; 49(2): 255-61, 1996 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8606328

RESUMEN

To characterize and compare the toxicity profiles of aspirin and acetaminophen when used by large populations, all records of adverse drug reactions to these drugs reported to the Spanish Drug Monitoring System from 1982 to 1991 were analyzed. According to these data, aspirin-induced reactions were more serious than those reactions to acetaminophen; the severity of all the reactions in both cases was associated with time of exposure and with the accumulated dose administered. For GI reactions to aspirin no association was found between severity and time of exposure or dose, although an association with age was found. There were no differences between the proportions of deaths, malformations, and renal damage recorded for either of the two groups. Proportions of hematological and hepatic disturbances were greater with acetaminophen. Adverse drug reaction data for aspirin and acetaminophen from spontaneous reporting seem to be consistent with data coming from observational studies.


Asunto(s)
Acetaminofén/efectos adversos , Sistemas de Registro de Reacción Adversa a Medicamentos , Aspirina/efectos adversos , Adolescente , Adulto , Sistemas de Registro de Reacción Adversa a Medicamentos/tendencias , Distribución por Edad , Anciano , Causas de Muerte , Niño , Preescolar , Recolección de Datos , Medicina Familiar y Comunitaria , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , España/epidemiología
4.
Artículo en Español | MEDLINE | ID: mdl-7484303

RESUMEN

Data from 62 schizophrenic patients (DSM III), aged 18 to 30, who were treated in the public medical system, and showed a relapse in 1987, after an one-year-follow up, were analyzed. It was observed that cannabis and alcohol use increased the probability of a relapse of schizophrenia in the follow-up period, whilst moderate alcohol use (less than 70 cc of pure alcohol/day) had no influence in the probability of relapse.


Asunto(s)
Cannabis , Etanol , Esquizofrenia/complicaciones , Trastornos Relacionados con Sustancias/complicaciones , Trastornos Relacionados con Sustancias/epidemiología , Adolescente , Adulto , Femenino , Humanos , Masculino , Pronóstico , Estudios Prospectivos , Escalas de Valoración Psiquiátrica , Recurrencia , Esquizofrenia/diagnóstico
5.
Br J Psychiatry ; 164(5): 679-81, 1994 May.
Artículo en Inglés | MEDLINE | ID: mdl-7921721

RESUMEN

Data were analysed from 62 schizophrenic patients between 18 and 30 years of age, treated at the community mental health centres in Navarra, who had relapsed and then completed a one-year follow-up study. Factors influencing the course of illness during follow-up were: continuing cannabis consumption; previous cannabis intake; non-compliance with treatment; and stress.


Asunto(s)
Abuso de Marihuana/epidemiología , Esquizofrenia/epidemiología , Psicología del Esquizofrénico , Adolescente , Adulto , Comorbilidad , Dronabinol/efectos adversos , Femenino , Estudios de Seguimiento , Humanos , Masculino , Abuso de Marihuana/psicología , Abuso de Marihuana/rehabilitación , Cooperación del Paciente/psicología , Recurrencia , Esquizofrenia/rehabilitación , Estrés Psicológico/complicaciones , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA